SEC filing · 8-K

Teva Pharmaceutical Industries Ltd: Material agreement

Teva subsidiaries issued multiple series of euro and US dollar senior notes to fund debt redemptions and general corporate purposes.

Filed September 16, 2026

Neutral news

What happened

On September 16, 2026, three finance subsidiaries of Teva issued new senior notes across five tranches in euros and US dollars.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov All documents of this filing

Back to Teva Pharmaceutical Industries Ltd

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.